Gut Microbiome Dysbiosis and Immunometabolism: New Frontiers for Treatment of Metabolic Diseases
Open accessThe DOI matches its Crossref record; 100 of the 101 references it cites were found in a registry or an index.
Abstract
Maintenance of healthy human metabolism depends on a symbiotic consortium among bacteria, archaea, viruses, fungi, and host eukaryotic cells throughout the human gastrointestinal tract. Microbial communities provide the enzymatic machinery and the metabolic pathways that contribute to food digestion, xenobiotic metabolism, and production of a variety of bioactive molecules. These include vitamins, amino acids, short-chain fatty acids (SCFAs), and metabolites, which are essential for the interconnected pathways of glycolysis, the tricarboxylic acid/Krebs cycle, oxidative phosphorylation (OXPHOS), and amino acid and fatty acid metabolism. Recent studies have been elucidating how nutrients that fuel the metabolic processes impact on the ways immune cells, in particular, macrophages, respond to different stimuli under physiological and pathological conditions and become activated and acquire a specialized function. The two major inflammatory phenotypes of macrophages are controlled through differential consumption of glucose, glutamine, and oxygen. M1 phenotype is triggered by polarization signal from bacterial lipopolysaccharide (LPS) and Th1 proinflammatory cytokines such as interferon-γ, TNF-α, and IL-1 β, or both, whereas M2 phenotype is triggered by Th2 cytokines such as interleukin-4 and interleukin-13 as well as anti-inflammatory cytokines, IL-10 and TGF β, or glucocorticoids. Glucose utilization and production of chemical mediators including ATP, reactive oxygen species (ROS), nitric oxide (NO), and NADPH support effector activities of M1 macrophages. Dysbiosis is an imbalance of commensal and pathogenic bacteria and the production of microbial antigens and metabolites. It is now known that the gut microbiota-derived products induce low-grade inflammatory activation of tissue-resident macrophages and contribute to metabolic and degenerative diseases, including diabetes, obesity, metabolic syndrome, and cancer. Here, we update the potential interplay of host gut microbiome dysbiosis and metabolic diseases. We also summarize on advances on fecal therapy, probiotics, prebiotics, symbiotics, and nutrients and small molecule inhibitors of metabolic pathway enzymes as prophylactic and therapeutic agents for metabolic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to regulation of infection and commensal spread, microbiome-immune interactions are implicated in a variety of ‘non-communicable’ gastrointestinal diseases including inflammatory bowel disease (IBD)8 and celiac diseases,9 as well as extra-intestinal disorders ranging from rheumatic arthritis,10 metabolic syndrome,11 neurodegenerative disorder12 to malignancy.13”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [11]
In the citing paper
“Changes in this microbial equilibrium that is, dysbiosis can promote and influence the course of many intestinal and extra-intestinal diseases[14-16].”
From Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified (2019) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 2×
“Several important questions on the complex interaction between host and microbes in pathophysiology of obesity remain answered [49, 74, 75].”
BackgroundA human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823 · cited 2×
“Several important questions on the complex interaction between host and microbes in pathophysiology of obesity remain answered [49, 74, 75].”
BackgroundEnterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335 · cited 2×
“Unstimulated macrophages displaying M0 phenotype and exhibiting the differentiation surface markers CD68/ CD80//CD206 acquire and display the M1 phenotype (CD68/CD80//CD206) or M2 phenotype (CD68/ CD80/CD206/) after switching their metabolism and function in response to stimuli or polarization signals that initiate a…”
BackgroundThe gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245 · cited 1×
“Initial clues for the role of microorganisms in energy homeostasis and obesity appeared from the studies using germ-free animals [76].”
BackgroundDe Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579
Revised Estimates for the Number of Human and Bacteria Cells in the Body
Sender, R., Fuchs, S., & Milo, R. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002533 · Cited by 5,425 · cited 1×
“A collection of 100-400× 10(12) of bacteria inhabits and lives in mutualistic relationships in the human GI tract [3].”
BackgroundMiller, M. B., & Bassler, B. L. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.165 · Cited by 5,105 · cited 1×
“Finally, bacteria can inhibit the growth of their competitors by long distance microbial communication, via release of metabolites and quorum sensing peptides, which are considered a biological strategy for maintenance of density of commensal species, and elimination of pathogenic bacteria [23, 24].”
BackgroundThe gut microbiota shapes intestinal immune responses during health and disease
Round, J. L., & Mazmanian, S. K. (2009) · Nature Reviews Immunology · doi:10.1038/nri2515 · Cited by 5,029 · cited 3×
“Various studies using gene-deficient mice models have defined the direct and complex interplay of bacterial dysbiosis and genetic and environmental factors [35, 36, 44].”
BackgroundRichness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511 · cited 8×
“For instance, Akkermansia muciniphila is a mucindegrading bacterium in the phylum of Verrucomicrobia that is present in great abundance in healthy humans, but is present in reduced number in patients with inflammatory and gastrointestinal diseases, obesity, and type 2 diabetes (T2D) [34].”
BackgroundInfluentialFunctional interactions between the gut microbiota and host metabolism
Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387 · cited 4×
“Microorganisms also sense diverse environmental signals, including host hormones and nutrients, and respond to them by differential gene regulation and niche adaptation [13, 14].”
BackgroundInfluentialSuccinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176 · cited 7×
“Succinate is a strong proinflammatory mediator [51, 63].”
BackgroundInfluentialInteractions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 5×
“For instance, NOD1/ and NOD2/ transgenic mice have increased susceptibility not only to inflammatory bowel disease but also to type 1 diabetes and cancer [38, 39, 45, 46].”
BackgroundInfluentialFormation of short chain fatty acids by the gut microbiota and their impact on human metabolism
Morrison, D. J., & Preston, T. (2016) · Gut Microbes · doi:10.1080/19490976.2015.1134082 · Cited by 3,781 · cited 3×
“Metformin is a firstline medication for the treatment of T2D that significantly improves metabolic parameters such as body weight, insulin, glucose, leptin, and C-reactive protein plasma levels [96].”
BackgroundEvolution of mammals and their gut microbes
Ley, R. E., Hamady, M., Lozupone, C., Turnbaugh, P. J., Ramey, R. R., Bircher, J. S., Schlegel, M. L., Tucker, T. A., Schrenzel, M. D., Knight, R., et al. (2008) · Science · doi:10.1126/science.1155725 · Cited by 3,747 · cited 2×
“Transferring the microbiota from fat mice to germ-free mice hosts induces greater weight gain than in those receiving the microbiota from lean donors [49, 50].”
BackgroundThe impact of the gut microbiota on human health: an integrative view
Clemente, J. C., Ursell, L. K., Parfrey, L. W., & Knight, R. (2012) · Cell · doi:10.1016/j.cell.2012.01.035 · Cited by 3,710 · cited 1×
“The components of inflammasomes such as MyD88, TLRs, NODs, NLrp3/6, ASC, and caspase 1 and caspase 11 are known to play a control of the intestinal dysbiosis [29, 38, 39, 45, 46].”
BackgroundDuodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
A guide to immunometabolism for immunologists
O'Neill, L. A. J., Kishton, R. J., & Rathmell, J. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.70 · Cited by 3,315 · cited 3×
“Immunometabolism comprehends the hub of biochemical activities carry out by immune cells to modulate gene expression profile and switching metabolic pathways and their key enzymes [53].”
BackgroundPersonalized nutrition by prediction of glycemic responses
Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., Ben-Yacov, O., Lador, D., Avnit-Sagi, T., Lotan-Pompan, M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.001 · Cited by 2,929 · cited 1×
“Studies on the relationship among gut microbes, obesity, insulin resistance, and metabolic syndrome have shown an intricate interplay between host diet, genetics, and microbiome compositional dynamics [49, 69, 70].”
BackgroundGut microbiota functions: metabolism of nutrients and other food components
Rowland, I., Gibson, G., Heinken, A., Scott, K., Swann, J., Thiele, I., & Tuohy, K. (2018) · European Journal of Nutrition · doi:10.1007/s00394-017-1445-8 · Cited by 2,878 · cited 22×
“Under anaerobic conditions, species belonging to the Bacteroides genus, and to the Clostridiaceae and Lactobacillaceae families, in special, Citrobacter and Serratia strains, produce short-chain fatty acids (SCFAs) which are volatile fat acids able to cross the blood-brain barrier via monocarboxylate transporters.”
BackgroundInfluentialMetabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
Wikoff, W. R., Anfora, A. T., Liu, J., Schultz, P. G., Lesley, S. A., Peters, E. C., & Siuzdak, G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812874106 · Cited by 2,677
Microbiota and SCFA in lean and overweight healthy subjects
Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., & Hardt, P. D. (2010) · Obesity · doi:10.1038/oby.2009.167 · Cited by 2,457 · cited 2×
“They bind to GPR41 and GPR43 receptors (free fatty acid receptors 2 and 3, FFARs 2/3) in intestinal L cells signaling the release of GLP-1 and peptide YY [78].”
BackgroundDethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060280 · Cited by 2,361 · cited 2×
“The use of antibiotics permanently modifies gut microbial community [89].”
BackgroundAn integrated catalog of reference genes in the human gut microbiome
MetaHIT Consortium, Li, J., Jia, H., Cai, X., Zhong, H., Feng, Q., Sunagawa, S., Arumugam, M., Kultima, J. R., Prifti, E., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2942 · Cited by 2,164
Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
MetaHIT consortium, Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S., Prifti, E., Vieira-Silva, S., Gudmundsdottir, V., et al. (2015) · Nature · doi:10.1038/nature15766 · Cited by 2,116
The microbiome and innate immunity
Thaiss, C. A., Zmora, N., Levy, M., & Elinav, E. (2016) · Nature · doi:10.1038/nature18847 · Cited by 2,012 · cited 2×
“NK cells and ILC1 produce large amounts of IFN-γ, antimicrobial peptides (AMPs), granulysin, defensins, lysozyme, and Reg IIIγ, which together play critical functions on the regulation of microbial ecology and immune surveillance [24, 31, 39, 40].”
BackgroundBlundell, J. E., Baker, J. L., Boyland, E., Blaak, E., Charzewska, J., de Henauw, S., Frühbeck, G., Gonzalez-Gross, M., Hebebrand, J., Holm, L., et al. (2017) · Obesity Facts · doi:10.1159/000455952 · Cited by 1,945
Lloyd-Price, J., Abu-Ali, G., & Huttenhower, C. (2016) · Genome Medicine · doi:10.1186/s13073-016-0307-y · Cited by 1,891
Recovery of nearly 8,000 metagenome-assembled genomes substantially expands the tree of life
Parks, D. H., Rinke, C., Chuvochina, M., Chaumeil, P.-A., Woodcroft, B. J., Evans, P. N., Hugenholtz, P., & Tyson, G. W. (2017) · Nature Microbiology · doi:10.1038/s41564-017-0012-7 · Cited by 1,882 · cited 1×
“A common set of prevalent microbial species found in normal human stools includes the Clostridiales species such as Coprococcus, Ruminococcus, Eubacterium, Bacteroides dorei and fragilis, and Alistipes finegoldii and onderdonkii [7, 8].”
BackgroundObesity is associated with hypothalamic injury in rodents and humans.
Thaler, J. P., Yi, C.-X., Schur, E. A., Guyenet, S. J., Hwang, B. H., Dietrich, M. O., Zhao, X., Sarruf, D. A., Izgur, V., Maravilla, K. R., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59660 · Cited by 1,857 · cited 1×
“High-fat diet-induced obesity leads also to chronic low-grade hypothalamic inflammation and activation of both microglia and astrocytes [81].”
BackgroundThe microbiota in adaptive immune homeostasis and disease
Honda, K., & Littman, D. R. (2016) · Nature · doi:10.1038/nature18848 · Cited by 1,846 · cited 5×
“For instance, NOD1/ and NOD2/ transgenic mice have increased susceptibility not only to inflammatory bowel disease but also to type 1 diabetes and cancer [38, 39, 45, 46].”
BackgroundInfluentialCani, P. D., Neyrinck, A. M., Fava, F., Knauf, C., Burcelin, R. G., Tuohy, K. M., Gibson, G. R., & Delzenne, N. M. (2007) · Diabetologia · doi:10.1007/s00125-007-0791-0 · Cited by 1,774 · cited 2×
“In contrast, the administration of Bifidobaterium infantis in mice reduces the production of proinflammatory cytokines while promoting white adipose tissue gain [68, 71].”
BackgroundThe short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism
Frost, G., Sleeth, M. L., Sahuri-Arisoylu, M., Lizarbe, B., Cerdan, S., Brody, L., Anastasovska, J., Ghourab, S., Hankir, M., Zhang, S., et al. (2014) · Nature Communications · doi:10.1038/ncomms4611 · Cited by 1,771 · cited 1×
“This compound plays a central role in prevention of weight gain through an anorectic effect [82].”
BackgroundHow dying cells alert the immune system to danger
Kono, H., & Rock, K. L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2215 · Cited by 1,737 · cited 1×
“A variety of membrane and intracellular receptors named “pattern recognition receptors” or PRRs expressed on the epithelial and immune cells act as sensors of bacterial and cellular products, which are named the pathogen-associated molecular patterns (PAMPs) and damaged-associated molecular patterns (DAMPs) [41, 42].”
BackgroundImmunometabolism governs dendritic cell and macrophage function
O’Neill, L. A. J., & Pearce, E. J. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151570 · Cited by 1,694 · cited 4×
“The classical activation pathway or reprogramming pathway in M1 macrophages promotes the accumulation of citrate and high production of NO, ROS, cytokines, and prostaglandins [60, 61].”
BackgroundInfluentialThe interplay between the intestinal microbiota and the brain
Collins, S. M., Surette, M., & Bercik, P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2876 · Cited by 1,611 · cited 3×
“Some of these factors act as major neurotransmitters and modulators of the brain-gut axis, and serotonin has central roles in sexuality, substance addiction, appetite, emotions, and stress response [18].”
BackgroundReciprocal interactions of the intestinal microbiota and immune system
Maynard, C. L., Elson, C. O., Hatton, R. D., & Weaver, C. T. (2012) · Nature · doi:10.1038/nature11551 · Cited by 1,598 · cited 3×
“The components of inflammasomes such as MyD88, TLRs, NODs, NLrp3/6, ASC, and caspase 1 and caspase 11 are known to play a control of the intestinal dysbiosis [29, 38, 39, 45, 46].”
BackgroundLampropoulou, V., Sergushichev, A., Bambouskova, M., Nair, S., Vincent, E. E., Loginicheva, E., Cervantes-Barragan, L., Ma, X., Huang, S. C.-C., Griss, T., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.004 · Cited by 1,541 · cited 2×
“Itaconate is one important metabolite formed in the second flux deviation or “break point’ of the Krebs cycle pathway during macrophage transition from inactive to proinflammatory state [65].”
BackgroundPrebiotics: The Concept Revisited1,
Roberfroid, M. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.3.830s · Cited by 1,498 · cited 4×
“Dietary prebiotics are known to provide immune and metabolic benefits to the host [14, 86].”
BackgroundInfluentialPalsson-McDermott, E. M., Curtis, A. M., Goel, G., Lauterbach, M. A. R., Sheedy, F. J., Gleeson, L. E., van den Bosch, M. W. M., Quinn, S. R., Domingo-Fernandez, R., Johnston, D. G. W., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.005 · Cited by 1,397 · cited 1×
“HIF1α interacts with pyruvate kinase isoenzyme M2 (PKM2) and promotes the expression of HIF1α-induced genes required for glycolysis [64].”
BackgroundBile acids and the gut microbiome
Ridlon, J. M., Kang, D. J., Hylemon, P. B., & Bajaj, J. S. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000057 · Cited by 1,329 · cited 1×
“Bile acids, for example, deoxycholic acid, have antimicrobial effects on microbes of the gut and also induce the synthesis of antimicrobial peptides by gut epithelial tissue [17].”
BackgroundAcetate mediates a microbiome–brain–β-cell axis to promote metabolic syndrome
Perry, R. J., Peng, L., Barry, N. A., Cline, G. W., Zhang, D., Cardone, R. L., Petersen, K. F., Kibbey, R. G., Goodman, A. L., & Shulman, G. I. (2016) · Nature · doi:10.1038/nature18309 · Cited by 1,299 · cited 3×
“The neuroimmuno-endocrine pathway is crucial for glucose homeostasis and control of adiposity in obese people recovering from bariatric surgery [80].”
BackgroundInfluentialStrains, functions and dynamics in the expanded Human Microbiome Project
Lloyd-Price, J., Mahurkar, A., Rahnavard, G., Crabtree, J., Orvis, J., Hall, A. B., Brady, A., Creasy, H. H., McCracken, C., Giglio, M. G., et al. (2017) · Nature · doi:10.1038/nature23889 · Cited by 1,267
Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion
Byndloss, M. X., Olsan, E. E., Rivera-Chávez, F., Tiffany, C. R., Cevallos, S. A., Lokken, K. L., Torres, T. P., Byndloss, A. J., Faber, F., Gao, Y., et al. (2017) · Science · doi:10.1126/science.aam9949 · Cited by 1,215 · cited 1×
“unequivocally demonstrated that dysbiosis could be caused by high levels of oxygen and nitrates, which are compounds that contribute to the growth of Escherichia and Salmonella species [28].”
BackgroundGut Microbiota and Metabolic Endotoxemia in Young Obese Mexican Subjects
Radilla-Vázquez, R. B., Parra-Rojas, I., Martínez-Hernández, N. E., Márquez-Sandoval, Y. F., Illades-Aguiar, B., & Castro-Alarcón, N. (2016) · Obesity Facts · doi:10.1159/000442479 · Cited by 1,196
Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production
Michelucci, A., Cordes, T., Ghelfi, J., Pailot, A., Reiling, N., Goldmann, O., Binz, T., Wegner, A., Tallam, A., Rausell, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218599110 · Cited by 1,191 · cited 2×
“In contrast, the administration of Bifidobaterium infantis in mice reduces the production of proinflammatory cytokines while promoting white adipose tissue gain [68, 71].”
BackgroundMitochondria are the powerhouses of immunity
Mills, E. L., Kelly, B., & O'Neill, L. A. J. (2017) · Nature Immunology · doi:10.1038/ni.3704 · Cited by 1,161 · cited 7×
“Glycolysis is a preferential pathway for the activation of dendritic cells, CD4 T helper 1 (Th1), Th2, and Th17 cells, NK cells, and cytotoxic CD8 cells [51, 52].”
BackgroundInfluentialInflammasome Complexes: Emerging Mechanisms and Effector Functions
Rathinam, V. A. K., & Fitzgerald, K. A. (2016) · Cell · doi:10.1016/j.cell.2016.03.046 · Cited by 1,101 · cited 3×
“Extracellular and intracellular complexes formed by DAMPs and PAMPs and NOD/ NLR receptors constitute the inflammasomes [43].”
BackgroundNext-Generation Beneficial Microbes: The Case of Akkermansia muciniphila
Cani, P. D., & de Vos, W. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01765 · Cited by 1,058 · cited 3×
“Ingestion of inulin or oligofructose improves metabolic disorders associated with obesity, including insulin resistance and metabolic endotoxemia [34, 71, 79].”
BackgroundMetabolic Reconstruction for Metagenomic Data and Its Application to the Human Microbiome
Abubucker, S., Segata, N., Goll, J., Schubert, A. M., Izard, J., Cantarel, B. L., Rodriguez-Mueller, B., Zucker, J., Thiagarajan, M., Henrissat, B., et al. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002358 · Cited by 1,056
Gough, E., Shaikh, H., & Manges, A. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir632 · Cited by 1,003 · cited 1×
“Fecal bacteriotherapy is a clinical procedure, in which a liquid suspension of stool from a human donor (a family member or a disease-free screened donor) is inoculated into gut’s patients to restore gut microbiota in refractory cases of Clostridium difficile colorectal infection after antibiotic therapy [90, 91].”
BackgroundMetabolic regulation of immune responses
Ganeshan, K., & Chawla, A. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120236 · Cited by 926 · cited 9×
“Glycolysis is a preferential pathway for the activation of dendritic cells, CD4 T helper 1 (Th1), Th2, and Th17 cells, NK cells, and cytotoxic CD8 cells [51, 52].”
BackgroundInfluentialBäckhed, F., Fraser, C. M., Ringel, Y., Sanders, M. E., Sartor, R. B., Sherman, P. M., Versalovic, J., Young, V., & Finlay, B. B. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.10.012 · Cited by 836 · cited 6×
“Disruption of the dynamic interrelation between the host and the microbial communities causes dysbiosis, which is a bacterial imbalance between aerobic and facultative anaerobic bacteria ratios [1, 2].”
BackgroundInfluentialMetformin-associated lactic acidosis: current perspectives on causes and risk
DeFronzo, R., Fleming, G. A., Chen, K., & Bicsak, T. A. (2016) · Metabolism · doi:10.1016/j.metabol.2015.10.014 · Cited by 658 · cited 1×
“Metformin causes a switch from OXPHOS to aerobic glycolysis [97].”
BackgroundMicrobiota restoration: natural and supplemented recovery of human microbial communities
Reid, G., Younes, J. A., Van der Mei, H. C., Gloor, G. B., Knight, R., & Busscher, H. J. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2473 · Cited by 588 · cited 4×
“Along the transition of infancy to adult life, increase in food sources drives the complexity and diversity of bacterial communities of the genera Bacteroides, Parabacteroides (Bacteroidetes), and Clostridium (Firmicutes) [1, 2, 25, 26].”
BackgroundInfluentialVerdam, F. J., Fuentes, S., de Jonge, C., Zoetendal, E. G., Erbil, R., Greve, J. W., Buurman, W. A., de Vos, W. M., & Rensen, S. S. (2013) · Obesity · doi:10.1002/oby.20466 · Cited by 587 · cited 3×
“Comparative studies in lean and obese animal models have indicated that low Bacteroidetes/Firmicutes ratio is a hallmark of obesity [33].”
BackgroundResultImpact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity
Vrieze, A., Out, C., Fuentes, S., Jonker, L., Reuling, I., Kootte, R. S., van Nood, E., Holleman, F., Knaapen, M., Romijn, J. A., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.11.034 · Cited by 578
Cordes, T., Wallace, M., Michelucci, A., Divakaruni, A. S., Sapcariu, S. C., Sousa, C., Koseki, H., Cabrales, P., Murphy, A. N., Hiller, K., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.685792 · Cited by 526 · cited 4×
“Inhibition of SDH with dimethylmalonate inhibits IL-1β expression, while increasing the production of immunosuppressive cytokine IL-10 [52, 63].”
BackgroundInfluentialKoren, O., Knights, D., Gonzalez, A., Waldron, L., Segata, N., Knight, R., Huttenhower, C., & Ley, R. E. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002863 · Cited by 508
Butyrate and other short-chain fatty acids as modulators of immunity: What relevance for health?
Meijer, K., de Vos, P., & Priebe, M. G. (2010) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32833eebe5 · Cited by 443 · cited 15×
“Under anaerobic conditions, species belonging to the Bacteroides genus, and to the Clostridiaceae and Lactobacillaceae families, in special, Citrobacter and Serratia strains, produce short-chain fatty acids (SCFAs) which are volatile fat acids able to cross the blood-brain barrier via monocarboxylate transporters.”
BackgroundInfluentialMetabolism of glucose, glutamine, long-chain fatty acids and ketone bodies by murine macrophages
Newsholme, P., Curi, R., Gordon, S., & Newsholme, E. A. (1986) · Biochemical Journal · doi:10.1042/bj2390121 · Cited by 424 · cited 2×
“Their study demonstrated that all glucose utilized by inflammatory macrophages was converted into lactate and very little of it was oxidized [54, 55].”
BackgroundJantsch, J., Chakravortty, D., Turza, N., Prechtel, A. T., Buchholz, B., Gerlach, R. G., Volke, M., Gläsner, J., Warnecke, C., Wiesener, M. S., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4697 · Cited by 414 · cited 11×
“Th2 cytokines, such as IL-4 and IL-13, regulate macrophage alternative pathway or M2 reprogramming pathway.”
BackgroundInfluentialThe role of the immune system in governing host-microbe interactions in the intestine
Brown, E. M., Sadarangani, M., & Finlay, B. B. (2013) · Nature Immunology · doi:10.1038/ni.2611 · Cited by 404 · cited 2×
“IgA is one important component of innate response to prevent invasion of the microorganisms into circulation [30].”
BackgroundThe mitochondrial citrate carrier: a new player in inflammation
Infantino, V., Convertini, P., Cucci, L., Panaro, M. A., Di Noia, M. A., Calvello, R., Palmieri, F., & Iacobazzi, V. (2011) · Biochemical Journal · doi:10.1042/bj20111275 · Cited by 385 · cited 1×
“The classical activation pathway or reprogramming pathway in M1 macrophages promotes the accumulation of citrate and high production of NO, ROS, cytokines, and prostaglandins [60, 61].”
BackgroundHeterogeneity of the gut microbiome in mice: guidelines for optimizing experimental design
Laukens, D., Brinkman, B. M., Raes, J., De Vos, M., & Vandenabeele, P. (2016) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuv036 · Cited by 379 · cited 3×
“The animal housing conditions and diet-induced microbiota composition are some examples that may be responsible for strain phenotypic differences in transgenic animals [47, 48].”
BackgroundHuman microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches
Belizário, J. E., & Napolitano, M. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01050 · Cited by 372 · cited 5×
“Disruption of the dynamic interrelation between the host and the microbial communities causes dysbiosis, which is a bacterial imbalance between aerobic and facultative anaerobic bacteria ratios [1, 2].”
BackgroundInfluentialSelf-citationThe therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus
Kootte, R. S., Vrieze, A., Holleman, F., Dallinga‐Thie, G. M., Zoetendal, E. G., de Vos, W. M., Groen, A. K., Hoekstra, J. B. L., Stroes, E. S., & Nieuwdorp, M. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01483.x · Cited by 351
The gut microbiome as therapeutic target
Cani, P. D., & Delzenne, N. M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.012 · Cited by 350 · cited 2×
“SCFAs, particularly, propionic and butyric acids, may directly prevent low-grade inflammatory response in obesity by controlling gut microbiota [88].”
BackgroundReijnders, D., Goossens, G. H., Hermes, G. D. A., Neis, E. P. J. G., van der Beek, C. M., Most, J., Holst, J. J., Lenaerts, K., Kootte, R. S., Nieuwdorp, M., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.016 · Cited by 348 · cited 1×
“Furthermore, in a study with 75 obese and prediabetic volunteers that underwent an 8-day antibiotic treatment (amoxicillin and vancomycin), the antibiotic-driven dysbiosis did not alter gut permeability, as confirmed by variation in LPS levels and expression of lipid metabolic enzymes [95].”
BackgroundRapid changes in the gut microbiome during human evolution
Moeller, A. H., Li, Y., Mpoudi Ngole, E., Ahuka-Mundeke, S., Lonsdorf, E. V., Pusey, A. E., Peeters, M., Hahn, B. H., & Ochman, H. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419136111 · Cited by 340
The microbiome and regulation of mucosal immunity
McDermott, A. J., & Huffnagle, G. B. (2014) · Immunology · doi:10.1111/imm.12231 · Cited by 334 · cited 3×
“For instance, polysaccharide A, α-galactosylceramide, and tryptophan metabolites produce by microbial communities stimulate immune cells to produce interleukin-22, Reg3γ, IgA, and interleukin-17 [37].”
BackgroundAntimicrobial peptides and gut microbiota in homeostasis and pathology
Ostaff, M. J., Stange, E. F., & Wehkamp, J. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201773 · Cited by 329
Swidsinski, A. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i8.1131 · Cited by 314
Lachmandas, E., Boutens, L., Ratter, J. M., Hijmans, A., Hooiveld, G. J., Joosten, L. A. B., Rodenburg, R. J., Fransen, J. A. M., Houtkooper, R. H., van Crevel, R., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.246 · Cited by 314
The gut microbiota and metabolic disease: current understanding and future perspectives
Arora, T., & Bäckhed, F. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12508 · Cited by 303 · cited 1×
“Individuals robustly colonized by bacteria and archeae of the genera Faecalibacterium, Bifidobacterium, Lactobacillus, Coprococcus, and Methanobrevibacter have significantly less tendency to develop metabolic disturbances and inflammation and, in turn, type 2 diabetes and ischemic cardiovascular disorders [49, 73].”
BackgroundSeeley, R. J., Chambers, A. P., & Sandoval, D. A. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.01.001 · Cited by 235 · cited 6×
“After bariatric surgery by Roux-en-Y gastric bypass (RYGB) methods, human and animal models change food preference [83, 84].”
BackgroundInfluentialCrosstalk between the microbiome and epigenome: messages from bugs
Qin, Y., & Wade, P. A. (2018) · The Journal of Biochemistry · doi:10.1093/jb/mvx080 · Cited by 194
Fecal Transplants: What Is Being Transferred?
Bojanova, D. P., & Bordenstein, S. R. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002503 · Cited by 190 · cited 6×
“Results of FMT treatment of people with diverse metabolic disorders have not been conclusive.”
BackgroundInfluentialNlrp6- and ASC-Dependent Inflammasomes Do Not Shape the Commensal Gut Microbiota Composition
Mamantopoulos, M., Ronchi, F., Van Hauwermeiren, F., Vieira-Silva, S., Yilmaz, B., Martens, L., Saeys, Y., Drexler, S. K., Yazdi, A. S., Raes, J., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.07.011 · Cited by 181 · cited 1×
“Various studies using gene-deficient mice models have defined the direct and complex interplay of bacterial dysbiosis and genetic and environmental factors [35, 36, 44].”
BackgroundCosta, F. R. C., Françozo, M. C. S., de Oliveira, G. G., Ignacio, A., Castoldi, A., Zamboni, D. S., Ramos, S. G., Câmara, N. O., de Zoete, M. R., Palm, N. W., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20150744 · Cited by 176 · cited 2×
“The components of inflammasomes such as MyD88, TLRs, NODs, NLrp3/6, ASC, and caspase 1 and caspase 11 are known to play a control of the intestinal dysbiosis [29, 38, 39, 45, 46].”
BackgroundFrom meta-omics to causality: experimental models for human microbiome research
Fritz, J. V., Desai, M. S., Shah, P., Schneider, J. G., & Wilmes, P. (2013) · Microbiome · doi:10.1186/2049-2618-1-14 · Cited by 174 · cited 3×
“The animal housing conditions and diet-induced microbiota composition are some examples that may be responsible for strain phenotypic differences in transgenic animals [47, 48].”
BackgroundPyruvate Kinase M2: A Potential Target for Regulating Inflammation
Alves-Filho, J. C., & Pålsson-McDermott, E. M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00145 · Cited by 171 · cited 1×
“TEPP-46 and DASA-58, two small molecule inhibitors of PKM2 (pyruvate kinase isozyme 2), inhibit LPS-induced HIF-1α and IL-1β, thereby promoting the reprogramming of M1 macrophages to M2 [63, 98].”
BackgroundMURPHY, C., & NEWSHOLME, P. (1998) · Clinical Science · doi:10.1042/cs0950397 · Cited by 141 · cited 1×
“Their study demonstrated that all glucose utilized by inflammatory macrophages was converted into lactate and very little of it was oxidized [54, 55].”
BackgroundRoy, U., Gálvez, E. J. C., Iljazovic, A., Lesker, T. R., Błażejewski, A. J., Pils, M. C., Heise, U., Huber, S., Flavell, R. A., & Strowig, T. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.097 · Cited by 140 · cited 3×
“In fact, distinct microbial communities and mechanisms can drive host’s susceptibility to diseases and influence on clinical outcomes [35].”
BackgroundNémeth, B., Doczi, J., Csete, D., Kacso, G., Ravasz, D., Adams, D., Kiss, G., Nagy, A. M., Horvath, G., Tretter, L., et al. (2016) · The FASEB Journal · doi:10.1096/fj.15-279398 · Cited by 136
Cell Death-Associated Molecular-Pattern Molecules: Inflammatory Signaling and Control
Sangiuliano, B., Pérez, N. M., Moreira, D. F., & Belizário, J. E. (2014) · Mediators of Inflammation · doi:10.1155/2014/821043 · Cited by 134 · cited 1×
“A variety of membrane and intracellular receptors named “pattern recognition receptors” or PRRs expressed on the epithelial and immune cells act as sensors of bacterial and cellular products, which are named the pathogen-associated molecular patterns (PAMPs) and damaged-associated molecular patterns (DAMPs) [41, 42].”
BackgroundSelf-citationHankir, M. K., Seyfried, F., Hintschich, C. A., Diep, T. A., Kleberg, K., Kranz, M., Deuther‐Conrad, W., Téllez, L. A., Rullmann, M., Patt, M., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.006 · Cited by 132 · cited 3×
“After bariatric surgery by Roux-en-Y gastric bypass (RYGB) methods, human and animal models change food preference [83, 84].”
BackgroundWarburg, O. H., Gawehn, K., & Geissler, A.-W. (1958) · PubMed · Cited by 111
A past and present overview of macrophage metabolism and functional outcomes
Curi, R., Mendes, R. D. S., Crispin, L. A. D. C., Norata, G. D., Sampaio, S. C., & Newsholme, P. (2017) · Clinical Science · doi:10.1042/cs20170220 · Cited by 108 · cited 1×
“A deep overview of macrophage metabolic pathways and phenotypic and functional outcomes is described elsewhere [62].”
BackgroundObesity and the gut microbiome: Striving for causality
Harley, I. T. W., & Karp, C. L. (2012) · Molecular Metabolism · doi:10.1016/j.molmet.2012.07.002 · Cited by 96 · cited 3×
“Studies on the relationship among gut microbes, obesity, insulin resistance, and metabolic syndrome have shown an intricate interplay between host diet, genetics, and microbiome compositional dynamics [49, 69, 70].”
BackgroundIntestinal Farnesoid X Receptor Signaling Modulates Metabolic Disease
Gonzalez, F. J., Jiang, C., Xie, C., & Patterson, A. D. (2017) · Digestive Diseases · doi:10.1159/000450908 · Cited by 95 · cited 1×
“The gut microbiota contributes to fat deposition through the regulation of the nuclear farnesoid X receptor (FXR), the bile acid receptor that is responsible for the regulation of bile acid synthesis, and hepatic triglyceride accumulation [16].”
BackgroundProtective and pro-inflammatory roles of intestinal bacteria
Reinoso Webb, C., Koboziev, I., Furr, K. L., & Grisham, M. B. (2016) · Pathophysiology · doi:10.1016/j.pathophys.2016.02.002 · Cited by 93
The development of probiotic treatment in obesity: a review
Mekkes, M. C., Weenen, T. C., Brummer, R. J., & Claassen, E. (2014) · Beneficial Microbes · doi:10.3920/bm2012.0069 · Cited by 87 · cited 1×
“Lactobacillus rhamnosus in combination with Lactobacillus gasseri and Bifidobacterium lactis may reduce weight gain, in particular, fat tissue mass adiposity, in humans [87].”
BackgroundHuman metabolic atlas: an online resource for human metabolism
Pornputtapong, N., Nookaew, I., & Nielsen, J. (2015) · Database · doi:10.1093/database/bav068 · Cited by 84
Fuchs, A. G., & Colonna, M. (2011) · European Journal of Microbiology and Immunology · doi:10.1556/eujmi.1.2011.4.1 · Cited by 30 · cited 1×
“NK cells and ILC1 produce large amounts of IFN-γ, antimicrobial peptides (AMPs), granulysin, defensins, lysozyme, and Reg IIIγ, which together play critical functions on the regulation of microbial ecology and immune surveillance [24, 31, 39, 40].”
BackgroundToward a True Bacteriotherapy for Clostridium difficile Infection
Rupnik, M. (2015) · New England Journal of Medicine · doi:10.1056/nejmcibr1500270 · Cited by 22 · cited 1×
“Fecal bacteriotherapy is a clinical procedure, in which a liquid suspension of stool from a human donor (a family member or a disease-free screened donor) is inoculated into gut’s patients to restore gut microbiota in refractory cases of Clostridium difficile colorectal infection after antibiotic therapy [90, 91].”
BackgroundPalmer, D. J., Metcalfe, J. R., & Prescott, S. L. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.06.038 · Cited by 15 · cited 2×
“Along the transition of infancy to adult life, increase in food sources drives the complexity and diversity of bacterial communities of the genera Bacteroides, Parabacteroides (Bacteroidetes), and Clostridium (Firmicutes) [1, 2, 25, 26].”
Background
Research works printed but not linked: 1
- 1958, Zeitschrift für Naturforschung B, 13b, 515
Cited by
Interaction between microbiota and immunity in health and disease
Zheng, D., Liwinski, T., & Elinav, E. (2020) · Cell Research · doi:10.1038/s41422-020-0332-7 · Cited by 3,947
The gut microbiota in anxiety and depression—A systematic review
Simpson, C. A., Diaz-Arteche, C., Eliby, D., Schwartz, O. S., Simmons, J. G., & Cowan, C. S. M. (2021) · Clinical Psychology Review · doi:10.1016/j.cpr.2020.101943 · Cited by 912
Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified
Bruno, G., Zaccari, P., Rocco, G., Scalese, G., Panetta, C., Porowska, B., Pontone, S., & Severi, C. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i22.2706 · Cited by 258
Effects of Virgin Micro- and Nanoplastics on Fish: Trends, Meta-Analysis, and Perspectives
Jacob, H., Besson, M., Swarzenski, P. W., Lecchini, D., & Metian, M. (2020) · Environmental Science & Technology · doi:10.1021/acs.est.9b05995 · Cited by 248
Tegegne, B. A., & Kebede, B. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09725 · Cited by 232
“Lacticaseibacillus rhamnosus, when mixed with Lactobacillus gasseri and Bifidobacterium lactis, has been demonstrated to inhibit weight gain in humans, specifically fat tissue mass adiposity, which strengthens the efficacy of probiotics in diabetes [91, 92].”
Background
Metadata
- Authors
- Belizário, J. E., Faintuch, J., & Garay-Malpartida, M.
- Affiliations
- Universidade de São Paulo (BR)
- Corresponding author
- Belizário, José E.
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2018-12-09
- Volume
- 2018
- Pages
- 1-12
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- PMC
- PMC6304917
- OpenAlex
- W2904076340
- Cited by
- 341
- References
- 101
- Citations by year
- 2026: 27 · 2025: 34 · 2024: 55 · 2023: 46 · 2022: 64 · 2021: 47 · 2020: 51 · 2019: 17
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Mediators of Inflammation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2015/18647-6, 2007/04513-1, 312206/2016-0, 308794/2014-1, 2011/188-37)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (2015/18647-6, 2007/04513-1, 312206/2016-0, 308794/2014-1, 2011/188-37)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (2015/18647-6, 2007/04513-1, 312206/2016-0, 308794/2014-1, 2011/188-37)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- gut dysbiosis, immunometabolism, macrophage polarization, M1/M2 macrophages, short-chain fatty acids, microbial metabolites, low-grade inflammation, metabolic disorders, obesity, diabetes mellitus, metabolic syndrome, cancer, fecal microbiota transplantation, probiotics, prebiotics, symbiotics, small molecule inhibitors, host-microbe interactions
- MeSH terms
- Gastrointestinal Microbiome, Animals, Humans, Macrophages, Metabolic Diseases, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.